参考图片
Expression of IFN-γ by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 6 hr with PMA (50 ng/ml; Sigma) and calcium ionophore A23187 (500 ng/ml; Sigma) in the presence of 2 µM BD GolgiStop™ (Cat. No. 554724). The PBMC were stained with PE-Cy™5 Mouse Anti-Human CD3 (Cat. No. 555334/561007), fixed, permeabilized, and subsequently stained with 0.125 µg of PE Mouse Anti-Human IFN-γ (Cat. No. 554552/557074/559326/561056). The binding of PE Mouse Anti-Human IFN-γ was blocked by preincubation of cells with Purified Mouse Anti-Human IFN-γ (Cat. No. 554549, 5 µg; right panel). The quadrant markers for the bivariate dot plot were set based on the autofluorescence controls and verified using the unlabeled antibody and ligand blocking controls.
Expression of IFN-γ by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 6 hr with PMA (50 ng/ml; Sigma) and calcium ionophore A23187 (500 ng/ml; Sigma) in the presence of 2 µM BD GolgiStop™ (Cat. No. 554724). The PBMC were stained with PE-Cy™5 Mouse Anti-Human CD3 (Cat. No. 555334/561007), fixed, permeabilized, and subsequently stained with 0.125 µg of PE Mouse Anti-Human IFN-γ (Cat. No. 554552/557074/559326/561056). The binding of PE Mouse Anti-Human IFN-γ was blocked by preincubation of cells with Purified Mouse Anti-Human IFN-γ (Cat. No. 554549, 5 µg; right panel). The quadrant markers for the bivariate dot plot were set based on the autofluorescence controls and verified using the unlabeled antibody and ligand blocking controls.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9653.html